Urinary podocalyxin identifies a pre-albuminuric kidney injury window and stratifies 12-year diabetic kidney disease risk in youth with type 1 diabetes mellitus
Pediatric Nephrology · 2026
DOI: 10.1007/s00467-026-07334-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Nephrology, 2026. Verfasst von Seniha Kiremitci Yilmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Paediatric Endocrinology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey. skyilmaz.dr@gmail.com. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Sialoglycoproteins, Diabetic Nephropathies, Albuminuria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Manisa Celal Bayar Üniversitesi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Microalbuminuria indices may miss early diabetic kidney disease (DKD) and can regress. Urinary podocyte and tubular injury biomarkers may detect subclinical kidney injury before albuminuria. We evaluated urinary podocyte- and tubule-derived biomarkers in adolescents/young adults with type 1 diabetes mellitus (T1DM) and compared 12-year prognostic performance with albuminuria. METHODS: A total of 130 participants with T1DM were screened; 109 were eligible and included in the baseline analysis, and 30 age-matched healthy controls were enrolled. Baseline urinary podocalyxin (u-PCX), nephrin (u-nephrin), and liver-type fatty acid-binding protein (u-LFABP) were measured by ELISA and indexed to creatinine; albuminuria was assessed by 24-h albumin excretion rate (u-AER) and spot albumin-to-creatinine ratio (u-ACR). Fifty-one participants were reassessed after 12 years; measurements were obtained at baseline and at the 12-year follow-up visit. Incident DKD (micro-/macroalbuminuria) was the primary outcome. Discrimination was assessed by ROC curves and Youden thresholds. RESULTS: At baseline, 90% had normoalbuminuria. Participants with normoalbuminuria had higher u-PCX/Cr, u-nephrin/Cr, and u-LFABP/Cr vs. controls (all p ≤ 0.001). Over 12 years, 7/51 developed DKD. Baseline u-PCX/Cr discriminated incident DKD (AUC 0.96; 95% CI 0.91-1.00):
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Paediatric Endocrinology, Faculty of Medicine, Celal Bayar University, Manisa, Turkey. skyilmaz.dr@gmail.com.
- Division of Paediatric Endocrinology and Metabolism, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
- Department of Clinical Biochemistry, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
Förderung
- Manisa Celal Bayar Üniversitesi
Zitieren
APA
Yilmaz, S. K., Ersoy, B., Bayar, N. T. I., Oran, A., & Taneli, F. (2026). Urinary podocalyxin identifies a pre-albuminuric kidney injury window and stratifies 12-year diabetic kidney disease risk in youth with type 1 diabetes mellitus. Pediatric Nephrology. https://doi.org/10.1007/s00467-026-07334-2
Vancouver
Yilmaz SK, Ersoy B, Bayar NTI, Oran A, Taneli F. Urinary podocalyxin identifies a pre-albuminuric kidney injury window and stratifies 12-year diabetic kidney disease risk in youth with type 1 diabetes mellitus. Pediatric Nephrology. 2026. doi:10.1007/s00467-026-07334-2
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, Seniha Kiremitci and Ersoy, Betul and Bayar, Nilay Tuğçe Işık and Oran, Arzu and Taneli, Fatma},
title = {Urinary podocalyxin identifies a pre-albuminuric kidney injury window and stratifies 12-year diabetic kidney disease risk in youth with type 1 diabetes mellitus},
journal = {Pediatric Nephrology},
year = {2026},
doi = {10.1007/s00467-026-07334-2}
}
EUVIMED